津药药业：产品取得注册证

每日经济新闻04-18

津药药业（SH 600488，收盘价：3.7元）4月18日晚间发布公告称，近日，津药药业股份有限公司子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。产品名称为“吸入用乙酰半胱氨酸溶液”。2023年1至12月份，津药药业的营业收入构成为：甾体激素类占比55.08%，制剂占比34.34%，氨基酸类原料药占比9.69%，其他业务占比...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2428514225?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-18 16:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2428514225","market":"sh","top_or_hot":-1,"title":"津药药业：产品取得注册证","media":"每日经济新闻","content":"<div>\n<p>津药药业（SH 600488，收盘价：3.7元）4月18日晚间发布公告称，近日，津药药业股份有限公司子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。产品名称为“吸入用乙酰半胱氨酸溶液”。2023年1至12月份，津药药业的营业收入构成为：甾体激素类占比55.08%，制剂占比34.34%，氨基酸类原料药占比9.69%，其他业务占比...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>津药药业：产品取得注册证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n津药药业：产品取得注册证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-18 16:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>津药药业（SH 600488，收盘价：3.7元）4月18日晚间发布公告称，近日，津药药业股份有限公司子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。产品名称为“吸入用乙酰半胱氨酸溶液”。2023年1至12月份，津药药业的营业收入构成为：甾体激素类占比55.08%，制剂占比34.34%，氨基酸类原料药占比9.69%，其他业务占比...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0102","symbol_name":"重组","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b","article_id":"2428514225","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181608418b34ad24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2428514225","pubTimestamp":1713427500,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"津药药业（SH 600488，收盘价：3.7元）4月18日晚间发布公告称，近日，津药药业股份有限公司子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。产品名称为“吸入用乙酰半胱氨酸溶液”。2023年1至12月份，津药药业的营业收入构成为：甾体激素类占比55.08%，制剂占比34.34%，氨基酸类原料药占比9.69%，其他业务占比0.73%。截至发稿，津药药业市值为40亿元。（文章来源：每日经济新闻）","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600488":"津药药业","BK0102":"重组","BK0028":"国家队","BK0012":"证金概念","BK0239":"医药制造"},"translate_title":"Jinyao Pharmaceutical: The product has obtained the registration certificate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600488":0.9},"content_text":"津药药业（SH 600488，收盘价：3.7元）4月18日晚间发布公告称，近日，津药药业股份有限公司子公司津药和平（天津）制药有限公司收到国家药品监督管理局核准签发的关于吸入用乙酰半胱氨酸溶液的《药品注册证书》。产品名称为“吸入用乙酰半胱氨酸溶液”。2023年1至12月份，津药药业的营业收入构成为：甾体激素类占比55.08%，制剂占比34.34%，氨基酸类原料药占比9.69%，其他业务占比0.73%。截至发稿，津药药业市值为40亿元。（文章来源：每日经济新闻）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428514225"}